Johnson & Johnson ends partnership with Bavarian Nordic on hepatitis B and HPV vaccines
- A Single US$2.15-Million Injection to Block 90% of Cancer Cell Formation
- WIV: Prevention of New Disease X and Investigation of the Origin of COVID-19
- Why Botulinum Toxin Reigns as One of the Deadliest Poisons?
- FDA Approves Pfizer’s One-Time Gene Therapy for Hemophilia B: $3.5 Million per Dose
- Aspirin: Study Finds Greater Benefits for These Colorectal Cancer Patients
- Cancer Can Occur Without Genetic Mutations?
Johnson & Johnson ends partnership with Bavarian Nordic on hepatitis B and HPV vaccines
- Red Yeast Rice Scare Grips Japan: Over 114 Hospitalized and 5 Deaths
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Johnson & Johnson ends partnership with Bavarian Nordic on hepatitis B and HPV vaccines
On May 9, Johnson & Johnson announced that it had terminated its partnership and licensing agreement with Bavarian Nordic.
The main content of the agreement is to use Bavarian Nordic’s MVA-BN technology to develop potential vaccines against hepatitis B virus and human papilloma virus. Currently, J&J has not used the technology to develop a hepatitis B vaccine.
For hepatitis B, Johnson & Johnson will continue to prioritize the use of its technology platform to develop related therapeutic drugs. Because hepatitis B remains a serious health problem, about 296 million people worldwide are affected by the disease, and nearly 900,000 people die from it every year.
For human papillomavirus, J&J does not intend to focus its research on its therapeutic vaccine because a preventive vaccine is already widely used.
However, J&J’s collaboration with the company on HIV and Ebola is still ongoing.
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
